Get started Log in

MEM — Memphasys Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
AU$12.35m
Enterprise Value
AU$15.41m
Revenue
AU$0.27m

Australia Stock Exchange release from MEMPHASYS : Acceleration of reproductive biotechnology portfolio
19/09/2021 23:22
Australia Stock Exchange release from MEMPHASYS : Appendix 3G correction
17/09/2021 08:31
Australia Stock Exchange release from MEMPHASYS : Notification regarding unquoted securities - MEM
14/09/2021 06:11
Australia Stock Exchange release from MEMPHASYS : Change of Director's Interest Notice - AC and AG
10/09/2021 09:34
Australia Stock Exchange release from MEMPHASYS : Appendix 3G
03/09/2021 24:00
Australia Stock Exchange release from MEMPHASYS : Notification regarding unquoted securities - MEM
01/09/2021 08:20
Australia's Memphasys climbs most in 3 months on Hydrix compensation for delay
01/09/2021 05:36
Brief: Memphasys Says Reaches Settlement Agreement With Hydrix
31/08/2021 23:29
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 08:21:26
31/08/2021 23:10
Australia Stock Exchange release from MEMPHASYS : MEM reaches settlement agreement with Hydrix
31/08/2021 23:10
Australia Stock Exchange release from MEMPHASYS : HYD: Commercial arrangement between Hydrix and Memphasys
31/08/2021 10:28
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 19:39:17
31/08/2021 10:28
Australia Stock Exchange release from MEMPHASYS : FY21 Corporate Governance Statement and Appendix 4G
31/08/2021 24:09
Australia Stock Exchange release from MEMPHASYS : FY21 Full Year Statutory Accounts
30/08/2021 10:03
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 19:13:19
30/08/2021 10:02
Australia Stock Exchange release from MEMPHASYS : Preliminary Final Report
30/08/2021 10:02
Australia Stock Exchange release from MEMPHASYS : Results of General Meeting
24/08/2021 07:00
Australia Stock Exchange release from MEMPHASYS : General Meeting to be held as a Virtual Meeting of members
20/08/2021 05:04
Australia Stock Exchange release from MEMPHASYS : Global andrology expert, Professor John Aitken, joins MEM
05/07/2021 24:20
Australia's Memphasys sees best day in a month as IVF device passes verification
01/07/2021 02:21